383 related articles for article (PubMed ID: 27879338)
1. Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
Ahi YS; Zhang S; Thappeta Y; Denman A; Feizpour A; Gummuluru S; Reinhard B; Muriaux D; Fivash MJ; Rein A
mBio; 2016 Nov; 7(6):. PubMed ID: 27879338
[TBL] [Abstract][Full Text] [Related]
2. Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.
Li S; Ahmad I; Shi J; Wang B; Yu C; Zhang L; Zheng YH
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355687
[TBL] [Abstract][Full Text] [Related]
3. Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
Diehl WE; Guney MH; Vanzo T; Kyawe PP; White JM; Pizzato M; Luban J
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209034
[TBL] [Abstract][Full Text] [Related]
4. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
Usami Y; Popov S; Göttlinger HG
J Virol; 2014 Mar; 88(6):3443-54. PubMed ID: 24403584
[TBL] [Abstract][Full Text] [Related]
5. S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
Chande A; Cuccurullo EC; Rosa A; Ziglio S; Carpenter S; Pizzato M
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13197-13202. PubMed ID: 27803322
[TBL] [Abstract][Full Text] [Related]
6. A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef.
Stoneham CA; Ramirez PW; Singh R; Suarez M; Debray A; Lim C; Jia X; Xiong Y; Guatelli J
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941773
[TBL] [Abstract][Full Text] [Related]
7. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
8. Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.
Wu Y; Olety B; Weiss ER; Popova E; Yamanaka H; Göttlinger H
mBio; 2019 Jun; 10(3):. PubMed ID: 31186327
[TBL] [Abstract][Full Text] [Related]
9. SERINC5 Potently Restricts Retrovirus Infection
Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
[TBL] [Abstract][Full Text] [Related]
10. The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.
Ahmad I; Li S; Li R; Chai Q; Zhang L; Wang B; Yu C; Zheng YH
J Biol Chem; 2019 Apr; 294(17):7013-7024. PubMed ID: 30862674
[TBL] [Abstract][Full Text] [Related]
11. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Usami Y; Wu Y; Göttlinger HG
Nature; 2015 Oct; 526(7572):218-23. PubMed ID: 26416733
[TBL] [Abstract][Full Text] [Related]
12. Feline Leukemia Virus-B Envelope Together With its GlycoGag and Human Immunodeficiency Virus-1 Nef Mediate Resistance to Feline SERINC5.
Cano-Ortiz L; Gu Q; de Sousa-Pereira P; Zhang Z; Chiapella C; Twizerimana AP; Lin C; Franco AC; VandeWoude S; Luedde T; Baldauf HM; Münk C
J Mol Biol; 2022 Mar; 434(6):167421. PubMed ID: 34954236
[TBL] [Abstract][Full Text] [Related]
13. SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.
Gonzalez-Enriquez GV; Escoto-Delgadillo M; Vazquez-Valls E; Torres-Mendoza BM
J Immunol Res; 2017; 2017():1548905. PubMed ID: 29359168
[TBL] [Abstract][Full Text] [Related]
14. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
15. Restriction of Influenza A Virus by SERINC5.
Lai KK; Munro JB; Shi G; Majdoul S; Compton AA; Rein A
mBio; 2022 Dec; 13(6):e0292322. PubMed ID: 36409124
[TBL] [Abstract][Full Text] [Related]
16. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
17. The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA.
Shi Y; Simpson S; Ahmed SK; Chen Y; Tavakoli-Tameh A; Janaka SK; Evans DT; Serra-Moreno R
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766367
[TBL] [Abstract][Full Text] [Related]
18. MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
Pizzato M
Proc Natl Acad Sci U S A; 2010 May; 107(20):9364-9. PubMed ID: 20439730
[TBL] [Abstract][Full Text] [Related]
19. Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.
Renner TM; Bélanger K; Lam C; Gerpe MCR; McBane JE; Langlois MA
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298890
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.
Bamunusinghe D; Liu Q; Plishka R; Dolan MA; Skorski M; Oler AJ; Yedavalli VRK; Buckler-White A; Hartley JW; Kozak CA
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
